Oligodendroglioma

About
Mappings

OncoTree: Oligodendroglioma (oncotree:ODG)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) IDH1 p.R132C Oligodendroglioma Vorasidenib FDA
Sensitivity (+) IDH1 p.R132G Oligodendroglioma Vorasidenib FDA
Sensitivity (+) IDH1 p.R132H Oligodendroglioma Vorasidenib FDA
Sensitivity (+) IDH1 p.R132L Oligodendroglioma Vorasidenib FDA
Sensitivity (+) IDH1 p.R132S Oligodendroglioma Vorasidenib FDA
Sensitivity (+) IDH2 p.R172K Oligodendroglioma Vorasidenib FDA
Sensitivity (+) IDH2 p.R172M Oligodendroglioma Vorasidenib FDA
Sensitivity (+) IDH2 p.R172G Oligodendroglioma Vorasidenib FDA
Sensitivity (+) IDH2 p.R172S Oligodendroglioma Vorasidenib FDA
Sensitivity (+) IDH2 p.R172W Oligodendroglioma Vorasidenib FDA
Sensitivity (+) IDH1 p.R132C Oligodendroglioma Vorasidenib HC
Sensitivity (+) IDH1 p.R132G Oligodendroglioma Vorasidenib HC
Sensitivity (+) IDH1 p.R132H Oligodendroglioma Vorasidenib HC
Sensitivity (+) IDH1 p.R132L Oligodendroglioma Vorasidenib HC
Sensitivity (+) IDH1 p.R132S Oligodendroglioma Vorasidenib HC
Sensitivity (+) IDH2 p.R172K Oligodendroglioma Vorasidenib HC
Sensitivity (+) IDH2 p.R172M Oligodendroglioma Vorasidenib HC
Sensitivity (+) IDH2 p.R172G Oligodendroglioma Vorasidenib HC
Sensitivity (+) IDH2 p.R172S Oligodendroglioma Vorasidenib HC
Sensitivity (+) IDH2 p.R172W Oligodendroglioma Vorasidenib HC